300 million people in Europe and the US have at least one chronic disease that may benefit from home health monitoring.
US and Europe market size for home health monitoring of chronic diseases > $11 billion last year
Problem is growing at 10 percent per year
25 percent of that population would benefit from existing home monitoring solutions currently available, while some 50 percent would benefit from integrating or connecting existing medical devices with their mobile phones.
- Berg Insight
EU and US The Market
Our focus is on improving the quality of care for aging and ill populations while delivering compelling cost advantages and benefits for healthcare providers Our value proposition
Aingeal General Purpose In-Hospital Monitor - July 2010 A clinical trial using the Aingeal monitor began in Massachusetts General Hospital in Boston in July 2010 The Aingeal device will be used in a surgical ward and will measure ecg, heart rate, respiration rate, temperature and motion. It communicates with patient records database via the hospital’s wi-fi network Trial 2
Trial 3 AMNCH Hospital Dublin V-Patch used to monitor cardiac patients at home http:// canberra.intelesens.com /Demo/
Technology Phase Trials and Testing Phase Adoption, Reimbursement and Procurement Phase Marketing and Sales Phase Ulster MGH Tallaght